Lexeo Therapeutics, Inc. (LXEO) Capital expenditures 2022–2025
Lexeo Therapeutics, Inc. (LXEO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$397,000FY2025 · since FY2022: $672,000 → $397,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $397,000 | -17.5% |
| FY2024 | $481,000 | +318.3% |
| FY2023 | $115,000 | -82.9% |
| FY2022 | $672,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice